Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Toth

Showing results (21-30 of 524) with videos related to

Pageof 53
Sort By:
Current Cardiology Reports|October 28, 2008
When high is low: raising low levels of high-density lipoprotein cholesterolPeter P Toth
Vascular Health and Risk Management|May 27, 2016
Triglyceride-rich lipoproteins as a causal factor for cardiovascular diseasePeter P Toth
Polskie Archiwum Medycyny Wewnetrznej|October 23, 2009
Should we target HDL cholesterol level in lowering cardiovascular risk?Peter P Toth
Journal of Clinical Lipidology|December 3, 2010
Activation of intracellular signaling systems by high-density lipoproteinsPeter P Toth
Current Cardiology Reports|August 27, 2010
Pharmacomodulation of high-density lipoprotein metabolism as a therapeutic intervention for atherosclerotic diseasePeter P Toth
Journal of Clinical Lipidology|May 7, 2013
Emerging LDL therapies: Mipomersen-antisense oligonucleotide therapy in the management of hypercholesterolemiaPeter P Toth
Postgraduate Medicine|June 11, 2013
Stroke prevention in patients with atrial fibrillation: focus on new oral anticoagulantsPeter P Toth
Annals of Medicine|June 4, 2014
Direct oral anticoagulants as alternative treatment options for the effective long-term treatment of patients with pulmonary embolism in primary care: a reviewPeter P Toth
Heart Failure Clinics|September 25, 2012
Epicardial steatosis, insulin resistance, and coronary artery diseasePeter P Toth
Vascular Health and Risk Management|March 2, 2016
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant eraPeter P Toth
Pageof 53

Showing results (21-30 of 524) with videos related to

Sort By:
Pageof 53
Current Cardiology Reports|October 28, 2008
When high is low: raising low levels of high-density lipoprotein cholesterolPeter P Toth
Vascular Health and Risk Management|May 27, 2016
Triglyceride-rich lipoproteins as a causal factor for cardiovascular diseasePeter P Toth
Polskie Archiwum Medycyny Wewnetrznej|October 23, 2009
Should we target HDL cholesterol level in lowering cardiovascular risk?Peter P Toth
Journal of Clinical Lipidology|December 3, 2010
Activation of intracellular signaling systems by high-density lipoproteinsPeter P Toth
Current Cardiology Reports|August 27, 2010
Pharmacomodulation of high-density lipoprotein metabolism as a therapeutic intervention for atherosclerotic diseasePeter P Toth
Journal of Clinical Lipidology|May 7, 2013
Emerging LDL therapies: Mipomersen-antisense oligonucleotide therapy in the management of hypercholesterolemiaPeter P Toth
Postgraduate Medicine|June 11, 2013
Stroke prevention in patients with atrial fibrillation: focus on new oral anticoagulantsPeter P Toth
Annals of Medicine|June 4, 2014
Direct oral anticoagulants as alternative treatment options for the effective long-term treatment of patients with pulmonary embolism in primary care: a reviewPeter P Toth
Heart Failure Clinics|September 25, 2012
Epicardial steatosis, insulin resistance, and coronary artery diseasePeter P Toth
Vascular Health and Risk Management|March 2, 2016
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant eraPeter P Toth
Pageof 53